The Heparins: Basic and Clinical Aspects
Autor David Greenen Limba Engleză Paperback – 10 noi 2020
- Describes new pharmaceuticals derived from heparin that are devoid of anticoagulant activity, but still retain anti-inflammatory and anti-proliferative properties
- Discusses the development of non-anticoagulant heparins for the treatment of diseases, including asthma and cancer
- Presents the history of the discovery of this biological agent, how it was isolated and characterized, and its use for the treatment of thrombotic disorders
Preț: 615.51 lei
Preț vechi: 874.90 lei
-30%
Puncte Express: 923
Carte tipărită la comandă
Livrare economică 31 octombrie-14 noiembrie
Livrare prin curier în România Termenul estimat este afișat lângă disponibilitate.
Transport gratuit pentru acest produs Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.
Specificații
ISBN-13: 9780128187814
ISBN-10: 0128187816
Pagini: 214
Ilustrații: 100 illustrations (75 in full color)
Dimensiuni: 152 x 229 x 19 mm
Greutate: 0.3 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0128187816
Pagini: 214
Ilustrații: 100 illustrations (75 in full color)
Dimensiuni: 152 x 229 x 19 mm
Greutate: 0.3 kg
Editura: ELSEVIER SCIENCE
Public țintă
Hematologists, pathologists, biomedical scientists, physicians (emergency medicine, internal medicine, cardiology, and surgery), pharmacists, students of medicine and pharmacy.Cuprins
Part I. Historical Development and Properties1. Anticoagulant Heparins2. Non-anticoagulant Heparins
Part II. Clinical Applications3. Prevention of Thrombosis4. Therapy for Thrombosis
Part III. Adverse Effects5. Bleeding, heparin-induced thrombocytopenia
Part II. Clinical Applications3. Prevention of Thrombosis4. Therapy for Thrombosis
Part III. Adverse Effects5. Bleeding, heparin-induced thrombocytopenia
Recenzii
"This is a useful addition to the library of hematologists, internists, pathologists, and other clinicians who use anticoagulant therapy. It is a helpful reference for the history of drug development and clinical trials in this area of medicine. Although many textbooks of hematology and internal medicine will contain some of this information, I am not aware of another recent book with this comprehensive focus." --Doody
Notă biografică
Dr. Green is a hematologist with 45 years of clinical & research experience and an expert on hemostasis and thrombosis. He teaches medical students, interns, residents, fellows, and practicing physicians and has organized symposia, given national and international presentations, and published extensively on bleeding and clotting disorders. His lectures to medical students on anticoagulant therapy have garnered teaching awards, and he has been a co-investigator on landmark clinical trials of heparin and low molecular weight heparin. He is the author or co-author of two dozen publications devoted to heparins, including 19 peer-reviewed research papers in major medical journals. He is also the author of two recent books, Linked by Blood: Hemophilia and AIDS, and Factor VIII and Von Willebrand Factor.